Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsDividends payablesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Dividends payables (2017 - 2025)

Selectis Health's Dividends payables history spans 9 years, with the latest figure at $83100.0 for Q3 2025.

  • For Q3 2025, Dividends payables rose 56.5% year-over-year to $83100.0; the TTM value through Sep 2025 reached $83100.0, up 56.5%, while the annual FY2024 figure was $53100.0, 73.53% up from the prior year.
  • Dividends payables for Q3 2025 was $83100.0 at Selectis Health, up from $75600.0 in the prior quarter.
  • Across five years, Dividends payables topped out at $83100.0 in Q3 2025 and bottomed at $7500.0 in Q1 2021.
  • The 5-year median for Dividends payables is $30600.0 (2023), against an average of $34940.0.
  • The largest annual shift saw Dividends payables changed 0.0% in 2021 before it soared 370.37% in 2024.
  • A 5-year view of Dividends payables shows it stood at $7500.0 in 2021, then changed by 0.0% to $7500.0 in 2022, then soared by 308.0% to $30600.0 in 2023, then surged by 73.53% to $53100.0 in 2024, then skyrocketed by 56.5% to $83100.0 in 2025.
  • Per Business Quant, the three most recent readings for GBCS's Dividends payables are $83100.0 (Q3 2025), $75600.0 (Q2 2025), and $68100.0 (Q1 2025).